- HGENQ Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
Humanigen (HGENQ) CORRESPCorrespondence with SEC
Filed: 27 Nov 19, 12:00am
HUMANIGEN, INC.
533 Airport Boulevard, Suite 400
Burlingame, California 94010
November 27, 2019
BY EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street N.E.
Washington, D.C. 20549-3561
Attention: Christine Westbrook
Re: | Humanigen, Inc. |
Registration Statement on Form S-1
Filed November 20, 2019
File No. 333-234801
Ladies and Gentlemen:
The undersigned registrant hereby requests that the effectiveness of the above-captioned Registration Statement on Form S-1 filed with the U.S. Securities and Exchange Commission on November 20, 2019 be accelerated so that the same will become effective at 4:30 p.m. Eastern Time on December 2, 2019, or as soon thereafter as practicable.
Very truly yours,
HUMANIGEN, INC.
By: | /s/ | Cameron Durrant | |
Name: | Cameron Durrant, M.D., MBA | ||
Title: | Chairman of the Board and Chief Executive Officer |
cc: | Kevin L. Vold |